2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on Esophageal & HCC: CRT + Trastuzumab vs. CRT in Esophageal and GE Junction Adenocarcinomas, Trastuzumab/Pertuzumab to FLOT, Donafenib vs. Sorafenib in 1L Advanced HCC
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Heloisa Soares
112 views
September 16, 2020
Comments 0
Login to view comments.
Click here to Login
GI